EPZ004777,
EPZ004777,
1338466-77-5,
EPZ 004777,
EPZ-004777,
1-(3-((((2R,3S,4R,5R)-5-(4-Amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(isopropyl)amino)propyl)-3-(4-(tert-butyl)phenyl)urea,
CHEMBL2169919,
7-{5-[(3-{[(4-Tert-Butylphenyl)carbamoyl]amino}propyl)(Propan-2-Yl)amino]-5-Deoxy-Beta-D-Ribofuranosyl}-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine,
WXRGFPHDRFQODR-ICLZECGLSA-N,
0QK,
GTPL7377,
SCHEMBL9274416,
DTXSID30719178,
CHEBI:124920,
C28H41N7O4,
EX-A1764,
2397AH,
ABP001131,
BDBM50396023,
Daclatasvir (BMS790052 pound(c),
s7353,
ZINC89469833,
AKOS022185751,
CS-2326,
SB19224,
NCGC00356803-12,
AC-27388,
BC600310,
HY-15227,
SC-83236,
FT-0771208,
ST24037168,
SW219207-1,
3-[3-({[(2R,3S,4R,5R)-5-{4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl}(propan-2-yl)amino)propyl]-1-(4-tert-butylphenyl)urea,
7-[5-Deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-?-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine,
7-[5-Deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine,
D09ENZ,
DOT1L inhibitors (leukemia), Epizyme/GSK,
DOT1L inhibitors (mixed lineage leukemia),
A4170,
DOT1L inhibitors (mixed lineage leukemia), Epizyme/GlaxoSmithKline,
1-[3-[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl-propan-2-ylamino]propyl]-3-(4-tert-butylphenyl)urea,